INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2019	Mar. 31, 2018
Income Statement [Abstract]
PATIENT REVENUES, net	$ 134,353	$ 141,285
EXPENSES:
Operating	108,113	112,278
Lease and rent expense	15,804	13,713
Professional liability	3,421	2,775
General and administrative	7,513	8,139
Depreciation and amortization	2,494	2,881
Total expenses	137,345	139,786
OPERATING INCOME (LOSS)	(2,992)	1,499
OTHER INCOME (EXPENSE):
Other income	160	51
Interest expense, net	(1,460)	(1,669)
Total other expense	(1,300)	(1,618)
LOSS FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	(4,292)	(119)
BENEFIT FOR INCOME TAXES	955	38
LOSS FROM CONTINUING OPERATIONS	(3,337)	(81)
LOSS FROM DISCONTINUED OPERATIONS:
Operating loss, net of tax expense of $0 and $11, respectively	(9)	(22)
NET LOSS	$ (3,346)	$ (103)
Per common share – basic
Continuing operations (in dollars per share)	$ (0.52)	$ (0.01)
Discontinued operations (in dollars per share)	0.00	0.00
Net income (loss) per common share – basic (dollars per share)	(0.52)	(0.01)
Per common share – diluted
Continuing operations (in dollars per share)	(0.52)	(0.01)
Discontinued operations (in dollars per share)	0.00	0.00
Net income (loss) per common share – diluted (dollars per share)	(0.52)	(0.01)
COMMON STOCK DIVIDENDS DECLARED PER SHARE OF COMMON STOCK (dollars per share)	$ 0	$ 0.055
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Basic (shares)	6,424	6,314
Diluted (shares)	6,424	6,314